Literature DB >> 2818769

Continuous changes in electroencephalographic topograms and auditory reaction time during simulated 21 ATA (atmospheres absolute) heliox saturation dives.

K Ozawa, J Tatsuno.   

Abstract

The present study was designed to investigate EEG changes during two simulated 21 ATA hyperbaric heliox saturation dives. Four professional male divers were attached to 13 electrodes over the scalp and compressed to 21 ATA by helium. Throughout the dives, EEGs were measured and stored on a magnetic FM tape recorder to calculate electroencephalographic topograms. Three patterns of slow wave increase were clearly distinguished by the electroencephalographic topogram during compression. The first pattern was caused by trains or bursts of theta waves which spread from the frontal region to the central region of the scalp. This pattern occurred at comparatively shallow depth and showed the slowest recovery during the bottom stage among three patterns. The second pattern found in two divers was caused by frontal midline theta bursts, which showed maximum activity at F2. The frontal midline theta bursts were augmented by a reaction time task. The third pattern was caused by vertex sharp waves which indicated a transition from sleep stage 1 to sleep stage 2. Neurophysiological meanings of these EEG patterns as well as the relationship between EEG changes and other indices were discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2818769     DOI: 10.2114/ahs1983.8.247

Source DB:  PubMed          Journal:  Ann Physiol Anthropol        ISSN: 0287-8429


  8 in total

Review 1.  Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population.

Authors:  Fawz S AlHarthi; Alya Qari; Alaa Edress; Malak Abedalthagafi
Journal:  NPJ Genom Med       Date:  2020-02-03       Impact factor: 8.617

2.  Single-Cell RNA Sequencing of Ovarian Cancer: Promises and Challenges.

Authors:  Shobhana Talukdar; Zenas Chang; Boris Winterhoff; Timothy K Starr
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  The implications of IDH mutations for cancer development and therapy.

Authors:  Christopher J Pirozzi; Hai Yan
Journal:  Nat Rev Clin Oncol       Date:  2021-06-15       Impact factor: 66.675

4.  Design, synthesis and cytotoxicity of the antitumor agent 1-azabicycles for chemoresistant glioblastoma cells.

Authors:  Mona Oliveira; Lourenço Luis Botelho de Santana; José Claudio Serafim; Airam Oliveira Santos; Michelle Pereira Quintino; José Tiago Menezes Correia; Fabiano Damasceno; José Ricardo Sabino; Thiago Rubens Cardim Pires; Paulo Lucas Cerqueira Coelho; Giselle Pinto de Faria Lopes; Henning Ulrich; Silvia Lima Costa; Silvio Cunha
Journal:  Invest New Drugs       Date:  2019-12-14       Impact factor: 3.850

Review 5.  Potential role of microRNAs as biomarkers in human glioblastoma: a mini systematic review from 2015 to 2020.

Authors:  Manuela Rocha de Menezes; Maria Eduarda Azevêdo Acioli; Ana Carolina Lemos da Trindade; Suéllen Pedrosa da Silva; Raul Emídio de Lima; Vanessa Gabryelle da Silva Teixeira; Luydson Richardson Silva Vasconcelos
Journal:  Mol Biol Rep       Date:  2021-05-25       Impact factor: 2.316

6.  Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastoma.

Authors:  Barbara Ricci; Thomas O Millner; Nicola Pomella; Xinyu Zhang; Loredana Guglielmi; Sara Badodi; Dario Ceric; Carolina Gemma; Erica Cognolato; Ying Zhang; Sebastian Brandner; Michael R Barnes; Silvia Marino
Journal:  Oncogene       Date:  2020-01-27       Impact factor: 9.867

7.  Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.

Authors:  Yinghua Li; Bo Li; Wei Li; Yuan Wang; Seçkin Akgül; Daniel M Treisman; Kevin A Heist; Brianna R Pierce; Benjamin Hoff; Cheng-Ying Ho; David O Ferguson; Alnawaz Rehemtulla; Siyuan Zheng; Brian D Ross; Jun Z Li; Yuan Zhu
Journal:  Nat Commun       Date:  2020-07-22       Impact factor: 14.919

Review 8.  Engineered cells as glioblastoma therapeutics.

Authors:  Aparna Ramanathan; Ian A J Lorimer
Journal:  Cancer Gene Ther       Date:  2021-03-22       Impact factor: 5.987

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.